| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| amgen kras approval | 1.22 | 0.1 | 6017 | 32 | 19 |
| amgen | 0.82 | 0.9 | 8585 | 6 | 5 |
| kras | 0.86 | 0.6 | 9235 | 63 | 4 |
| approval | 0.74 | 0.5 | 3255 | 58 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| amgen kras g12c fda approval | 0.88 | 0.4 | 3470 | 37 |
| kras g12c inhibitor amgen | 0.33 | 1 | 2284 | 98 |
| kras g12c inhibitor fda approval | 1.47 | 0.8 | 6868 | 86 |
| kras g12d inhibitor amgen | 1.27 | 0.1 | 3453 | 85 |
| fda approved kras g12c inhibitor | 0.16 | 0.5 | 4758 | 29 |
| kras g12c amg 510 | 1.11 | 0.3 | 500 | 8 |
| kras g12c clinical trial | 1.6 | 0.9 | 6222 | 63 |
| kras g12c competitive with attgraseb drug | 1.94 | 1 | 4174 | 100 |
| the clinical kras g12c inhibitor amg 510 | 0.16 | 0.5 | 28 | 76 |
| kras g12c inhibitor drugs | 0.69 | 0.5 | 1894 | 89 |
| what is kras g12c | 0.72 | 0.7 | 5361 | 38 |
| kras g12c on inhibitor | 1.85 | 0.1 | 1288 | 21 |
| kras g12c mutation testing | 0.25 | 0.1 | 2453 | 8 |
| kras g12c inhibitor 1 | 1.73 | 0.8 | 1176 | 31 |
| kras g12c mutation treatment | 1.17 | 0.6 | 6686 | 100 |
| kras g12c inhibitor-12 | 1.41 | 0.3 | 1754 | 87 |
| kras g12c inhibitor adagrasib | 1.63 | 0.1 | 6814 | 31 |
| kras g12c cell line | 1.43 | 0.8 | 4193 | 55 |
| kras g12d clinical trials | 0.15 | 0.1 | 1381 | 22 |
| kras g12d recombinant protein | 1.12 | 0.3 | 2127 | 29 |
| kras g12v clinical trial | 1.44 | 0.8 | 3048 | 77 |
| kras g12d/+ | 1.25 | 0.9 | 9559 | 11 |
